1. Background {#sec69591}
=============

Bacterial pericarditis is defined as the swelling and irritation of pericardium, which is caused by infection with various kinds of bacteria. As a result, the inflamed pericardium rubs against the heart and the patient may feel pain with fluid accumulating in the pericardial sac. Since the introduction of antibiotics, bacterial pericarditis has become rare. Pericarditis occurs most often in men between 20 and 50 years of age, usually following respiratory infections. It is also seen after heart surgery as well as skin or oral infections that produce bacteremia. Diagnosis is made when the bacteria is detected in pericardial fluid. Despite the recent improvements in the intraoperative management and postoperative care, late-onset pericardial effusions are an important cause of morbidity following heart surgery. Pericardial effusions may adversely affect the recovery phase and become life-threatening once tamponade leads to hemodynamic compromise ([@A19432R1], [@A19432R2]). Because of the recent and widespread use of anticoagulant medications as well as the increasing complexity of operations, the incidence of such effusions might be higher ([@A19432R3], [@A19432R4]). Therefore, it is important to have enough information on the manifestations, risk factors, and natural history of pericardial effusion in order to develop better protocols for its prevention, diagnosis, and treatment.

2. Objectives {#sec69592}
=============

The aim of this study was to determine the bacteriologic profile in patients with pericardial infections after cardiac surgery and in the course of their treatment. The results could be applied for prevention, diagnosis, and treatment in similar patients in Iran.

3. Patients and Methods {#sec69597}
=======================

3.1. Study Participants {#sec69593}
-----------------------

This prospective study was performed on the patients who underwent cardiac surgery with cardiopulmonary bypass at Rajaie Cardiovascular Medical and Research Center (RCMRC), the largest tertiary care center for cardiovascular disease in Tehran, IR Iran, from March 2011 to March 2012. A total of 158 patients with clinical, laboratory, and echocardiographic suggestive findings of pericarditis ([@A19432R1]) were registered and undergone the bacteriologic investigations. The mean age of patients was 70 ± 14 years (range, 5 months to 100 years) and majority of them were females (116 \[73.3%\]). The study protocol was approved by Research Board and Ethics Committee of RCMRC.

3.2. Smear Preparation and Culture of the Samples {#sec69594}
-------------------------------------------------

A single drop of the fluid was placed on a glass microscopic slide to form a smear. Gram's staining method was then performed to impart appropriate staining qualities to different microorganisms that might be found in the smear of the fluid. A laboratory specialist examined the stained slide under the microscope for the presence of bacteria. The organisms were identified based on their color, size, and shape ([@A19432R4]). By definition, infectious pericarditis is manifested by positive gram staining and fluid culture results with the use of conventional microbiologic methods. We have benefitted from the same policy. Fluid culture studies were done according to standard procedures. Two blood agar media were inoculated; one for anaerobic and another one for aerobic microorganisms. One chocolate agar medium (incubated in Candle jar), one MacConkey agar, and thioglycollate broth (as enrichment medium) were also used. All the inoculated plates were assessed after incubation for 24 hours. The plates that were negative for any microbial growth were further incubated for another 24 hours and subculture from an enrichment medium was performed to detect fastidious and slow-growing bacteria in the samples.

3.3. Identification of Positive Cases {#sec69595}
-------------------------------------

Bacteria that belong to the *Staphylococcus* and *Streptococcus* genera and Enterobacteriaceae family were identified according to the standard methods. *Staphylococcus* species were tested for coagulase positivity using rabbit plasma. DNase activity was also checked by means of DNase agar. Coagulase-negative and DNase-negative isolates were identified further by sucrose fermentation, ornithine decarboxylation, and urea hydrolysis. DNase-positive and coagulase-positive isolates were identified as *Staphylococcus aureus*.

3.4. Antibiotic Susceptibility Testing {#sec69596}
--------------------------------------

Antibiotic susceptibility testing of all the isolates was performed according to the Kirby-Bauer disk diffusion method, using Mueller-Hinton agar (MHA). The following antibiotic disks were used (provided by Hi-media, Padtan teb, ABTEK, ROSCO): penicillin (10 U), ciprofloxacin (5 µg), amikacin (30 µg), gentamycin (10 µg), tobramycin (10 µg), ceftriaxone (30 µg), cefepime (30 µg), imipenem (10 µg), ampicillin (10 µg), amoxicillin/clavulanate (30 µg), cefoxitin (30 µg), cefazolin (30 µg), and meropenem (10 µg). Cefoxitin was used to determine the methicillin-resistant *S. aureus*(MRSA) strains.

4. Results {#sec69599}
==========

4.1. Bacterial isolates {#sec69598}
-----------------------

A total of 158 samples were assessed in which only 30 cases (19%) had positive results for bacteria. Only two major species of microorganisms were isolated, namely *Staphylococcus* and *Streptococcus*. Of the 30 positive cases, *Staphylococcus* species were present in 27 specimens (90%). In this group, 26 isolates were coagulase negative and only one *S. aureus* isolate was found. The remaining three positive cases (10%) were from the *Streptococcus* species all of which were found to be *Streptococci viridans* ([Table 1](#tbl17724){ref-type="table"}).

###### Isolates of Different Species in Pericardial Fluid of Patients

  Isolated Organisms                 No. (%)
  ---------------------------------- -----------
  ***Staphylococcusepidermidis***    22 (73.3)
  ***Staphylococcusschleiferi***     2 (6.6)
  ***Staphylococcushaemolyticus***   1 (3.3)
  ***Staphylococcus aureus***        1 (3.3)
  ***Staphylococcuswarneri***        1 (3.3)
  ***Streptococcusviridans***        3 (3.3)

###### Antibiotic Sensitivity Pattern of Isolated Organisms ^[a](#fn14672){ref-type="table-fn"},[b](#fn14673){ref-type="table-fn"}^

                      *Staphylococcus aureus* (n = 1)   *Staphylococcusepidermidis* (n = 22)   *Staphylococcuswarneri* (n = 1)   *Staphylococcushaemolyticus* (n = 1)   *Staphylococcusschleiferi* (n = 1)   *Streptococcus viridans* (n = 2)
  ------------------- --------------------------------- -------------------------------------- --------------------------------- -------------------------------------- ------------------------------------ ----------------------------------
  **Amikacin**        1                                 17                                     0                                 1                                      1                                    0
  **Cefoxitin**       1                                 0                                      0                                 0                                      1                                    0
  **Ampicillin**      0                                 0                                      0                                 0                                      0                                    2
  **Tobramycin**      1                                 17                                     0                                 1                                      1                                    0
  **Ceftriaxone**     1                                 15                                     0                                 1                                      1                                    2
  **Ciprofloxacin**   1                                 18                                     0                                 1                                      1                                    2
  **Meropenem**       0                                 19                                     0                                 1                                      1                                    2
  **Penicillin**      0                                 0                                      0                                 0                                      0                                    2
  **Gentamycin**      1                                 17                                     0                                 1                                      1                                    0
  **Cefepime**        1                                 18                                     0                                 1                                      1                                    2
  **TMP/SMX**         1                                 11                                     0                                 1                                      1                                    0
  **Imipenem**        1                                 19                                     0                                 1                                      1                                    2

^a^ Abbreviation: TMP/SMX, Trimethoprim/Sulfamethoxazole (co-trimoxazole).

^b^Data are presented as No.

5. Discussion {#sec69600}
=============

Bacterial infections of pericardium are relatively uncommon; however, they are much more likely to form purulent effusions and to proceed to cardiac tamponade or pericardial constriction ([@A19432R5], [@A19432R6]). Purulent pericarditis is almost exclusively seen as a secondary infection in patients with serious underlying diseases such as AIDS and those undergoing hemodialysis, thoracic surgery, and chemotherapy ([@A19432R7], [@A19432R8]). It is not typically a primary infection but rather almost exclusively a complication of an underlying infection. In the pre-antibiotic era, patients most often showed bacterial pericarditis after pneumonia with empyema, and the most common germ was *Streptococcus pneumoniae* ([@A19432R9]). In the antibiotic era, the most common cause is *S. aureus* ([@A19432R10]). Recent studies have revealed a trend toward diverse bacteria; in addition, anaerobes have been reported as common causes of such infections ([@A19432R11], [@A19432R12]). On blood testing, patients with pericarditis show evidence of systemic inflammation such as leukocytosis and increased erythrocyte sedimentation rate (ESR). It can be technically difficult to obtain a sample from fluid or tissue aseptically, especially during an ongoing surgical procedure in an infected tissue. When dealing with organisms that belong to the normal skin flora, the question of contamination always arises ([@A19432R13], [@A19432R14]). In most cases, there are sufficient numbers of bacteria in the infected tissue that can be detected in primary cultures. We detected only one case of *S. aureus* infection from the primary cultures. This made it possible to report culturing results (i.e. bacteria and antibiogram) to the clinician faster than with the traditional method, that is, subculturing only from enrichment broth. In rare cases, subculturing from enrichment broth on day four was necessary to identify infection with coagulase-negative *Staphylococcus* (CNS) species microbiologically. In our study group that consisted of 30 infected patients with positive culture results, 20 (66.6%) were clinically considered to have an infection and 10 (33.3%) were considered otherwise. These paraclinical findings included leukocytosis (white blood cell \> 10000/mm^2^) and an elevated ESR (\> 40 mm/h). Adding a microbiologic standard for infection could help identify infected patients among those lacking obvious visible signs of infection. The probability for agreement between diagnosis of infection based on clinical signs and symptoms and diagnosis based on our microbiologic criterion was significant for all infected cases, which were mostly infected with CNS species. Our findings were different from what the other studies showed ([@A19432R15]). In other words, our study revealed that, infections with CNS species could be identified by general signs and symptoms of infection as well. Infection with *S. viridans* is rarely found in purulent pericarditis. In addition, it is usually combined with other micro-organisms ([@A19432R11]). The clinical course of infection with *S. viridans* is usually subacute or chronic, with low or absence of toxic signs ([@A19432R16]). The common sources of purulent pericarditis with *S. viridans* include mediastinitis from esophageal rupture, dental caries, retropharyngeal abscess, infective endocarditis, chest surgery, trauma, and pneumonia ([@A19432R9], [@A19432R10]). The possible source in our case might be related to dental procedures according to the history. The majority of the CNS species that cause pericarditis have been reported as methicillin resistant during the last decade ([@A19432R13]). The results demonstrated that eight of the CNS isolates were methicillin resistant. We did not have as many such cases as was reported Mossad et al. and Tegnell et al. who found methicillin-resistant CNS isolates in 73% and 92% of studied cases, respectively ([@A19432R13], [@A19432R17]). Another retrospective study from 1984 to 1995 in the same setting, found that 69% of CNS isolates were methicillin resistant ([@A19432R18]). As this resistance limits the therapeutic options, it is important not to overestimate the proportion of methicillin-resistant strains or the number of infected patients. To diagnose a postoperative pericarditis caused by staphylococci correctly, the susceptibility pattern to methicillin in the infective strain is essential, as the methicillin-sensitive strains can be treated with isoxazolyl penicillins and cephalosporins. We also found that most of the isolated CNS strains were sensitive to cephalosporins. An overestimation of methicillin resistance might lead to unnecessary use of vancomycin ([@A19432R15]), which should be avoided due to the risk for selection of genes coding for vancomycin resistance ([@A19432R19]). Moreover, it would consider the interest of the patient who might otherwise undergo a long-term course of intravenously administered antibiotic treatment. Purulent pericarditis is a potential lethal disease and should be considered as an indolent underlying disease of cardiac tamponade. A stat Gram staining as well as other pericardial effusion analysis should be performed in every patient with cardiac tamponade. Prompt percutaneous catheter drainage of pericardial fluid along with appropriate antibiotic therapy according to bedside Gram staining can rapidly terminate the life-threatening condition associated with purulent pericarditis and cardiac tamponade.
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